Menu Search
Equities

CureVac NV

1CVAC:MIL

CureVac NV

Actions
  • Price (EUR)3.30
  • Today's Change0.054 / 1.66%
  • Shares traded6.33k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 10:38 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.

  • Revenue in USD (TTM)58.41m
  • Net income in USD-282.67m
  • Incorporated2020
  • Employees999.00
  • Location
    CureVac NVFriedrich-Miescher-Str. 15TUEBINGEN 72076GermanyDEU
  • Phone+49 707198830
  • Fax+49 707 198831101
  • Websitehttps://www.curevac.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.